Gene: ITGB2
Official Full Name: integrin subunit beta 2provided by HGNC
Gene Summary: This gene encodes an integrin beta chain, which combines with multiple different alpha chains to form different integrin heterodimers. Integrins are integral cell-surface proteins that participate in cell adhesion as well as cell-surface mediated signalling. The encoded protein plays an important role in immune response and defects in this gene cause leukocyte adhesion deficiency. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08641 | ITGB2 Knockout cell line (HEK293) | Human | ITGB2 | 1:3~1:6 | Negative | Online Inquiry |
ITGB2 Gene Knockout Cell Lines are specifically engineered cell lines that have had the ITGB2 gene intentionally disrupted or deleted to study the functional implications of this gene in various biological processes. ITGB2, which encodes the integrin beta-2 subunit, plays a critical role in the formation of integrins that mediate cell-extracellular matrix interactions and are vital for leukocyte adhesion and migration, immune responses, and tissue development.
The primary function of these knockout cell lines is to provide a powerful tool for researchers to dissect the cellular mechanisms associated with ITGB2 deficiencies. By analyzing the alterations in cellular behavior, signaling pathways, and gene expression profiles, scientists can gain insights into the cellular roles of integrins in health and disease, including their implications in autoimmune disorders, inflammation, and cancer metastasis. The mechanisms of action include disrupted adhesive properties, reduced migratory capabilities, and altered cellular communication, allowing for a enhanced understanding of integrin-related pathways.
The scientific importance of ITGB2 Gene Knockout Cell Lines is paramount, as they enable the exploration of therapeutic targets and the development of novel interventions in both research and clinical contexts. These cell lines can facilitate the screening of drugs that modulate integrin function or behavior, thereby aiding in the identification of new treatment options for diseases linked to aberrant integrin signaling.
Compared to traditional wild-type cell lines, our ITGB2 Gene Knockout Cell Lines offer several advantages, including the elimination of confounding variables associated with native gene expression, leading to more precise studies. They provide a consistent and reproducible system for examining the effects of integrin dysfunction, with data that can be reliably translated into clinical implications.
These knockout cell lines represent an invaluable resource for researchers and clinicians alike, as they address critical gaps in our understanding of cell biology and disease progression. By investing in our ITGB2 Gene Knockout Cell Lines, you equip yourself with a state-of-the-art tool designed to enhance the clarity and impact of your experiments, ultimately accelerating scientific discovery.
As a leader in the field of genetic engineering and cell line development, our company is committed to providing high-quality, rigorously validated biological products that empower researchers to make breakthrough discoveries and drive innovation across various domains of biomedical research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.